Product
4-1BBζ EGFR806-EGFRt
1 clinical trial
16 indications
Indication
Pediatric Solid TumorIndication
Germ Cell TumorIndication
RetinoblastomaIndication
hepatoblastomaIndication
Wilms tumorIndication
Rhabdoid TumorIndication
cancerIndication
OsteosarcomaIndication
Ewing SarcomaIndication
RhabdomyosarcomaIndication
Synovial SarcomaIndication
Clear Cell SarcomaIndication
Malignant Peripheral Nerve Sheath TumorsIndication
Desmoplastic Small Round Cell TumorIndication
Soft Tissue SarcomaIndication
NeuroblastomaClinical trial
Phase I Study of EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young AdultsStatus: Recruiting, Estimated PCD: 2025-06-01